谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Datopotamab Deruxtecan (Dato-DXd; DS-1062), a TROP2 ADC, in patients with advanced NSCLC: Updated results of TROPION-PanTumor01 phase 1 study

Toshio Shimizu,Aaron E. Lisberg,Jacob M. Sands,Jonathan Greenberg,Penny Phillips,Naoyuki Tajima,Yui Kawasaki,Jessie Gu,Fumiaki Kobayashi,Noboru Yamamoto, Melissa Johnson,Funda Meric-Bernstam,Kiyotaka Yoh,Edward B. Garon,Rebecca S. Heist,Alexander Spira

ANNALS OF ONCOLOGY（2021）

引用 24|浏览28
暂无评分
关键词
NSCLC, antibody drug conjugate, TROP2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要